Paragraph 31 Format of the abstract of the final study reportF1
The abstract of the final study report for a non-interventional post-authorisation safety studies must be submitted in the following format—
title, with subtitles including date of the abstract and name and affiliation of main author;
keywords (not more than five keywords indicating the main study characteristics);
rationale and background;
research question and objectives;
study design;
setting;
subjects and study size, including dropouts;
variables and data sources;
results;
discussion (including, where relevant, an evaluation of the impact of study results on the risk–benefit balance of the product);
name of holder; and
names and affiliations of principal investigators.
Annotations
Textual amendments
- F1
Sch. 12A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 6 (as amended by S.I. 2019/1385, reg. 1, Sch. 1 para. 9 and S.I. 2020/1488, reg. 1, Sch. 2 para. 192); 2020 c. 1, Sch. 5 para. 1(1)